Fizyhealth
FountainRx company profile

FountainRx company profile: what is public, what to confirm

FountainRx Specialty Pharmacy is a national, independently owned specialty and infusion services provider founded in Tennessee, operating since 2012, with walk-in locations in Morristown and Nashville. Its September 2024 press release names CEO Joseph Huntsman and COO Ryan Hollingsworth, PharmD, announces licensure in all 50 states, and lists four accreditations — URAC specialty pharmacy and mail order, ACHC specialty pharmacy and compounding.

If you are doing vendor due diligence on FountainRx as a specialty partner, this page reports publicly verifiable facts and flags what to confirm directly — without filling gaps with guesses.

Compare Fizy Health vs FountainRx

Proudly Partnered With

What is publicly verifiable about FountainRx?

From FountainRx's public website, FAQ, and September 2024 press release, the verifiable company profile is: an independently owned specialty pharmacy providing compounding and specialty services since 2012 from Morristown, Tennessee, with a Nashville location; licensed in all 50 states for specialty pharmacy as of September 2024; accredited by URAC for specialty pharmacy and mail order and by ACHC for specialty pharmacy and compounding; led by partners Joseph Huntsman (CEO) and Ryan Hollingsworth, PharmD (COO); serving patients, providers, pharmaceutical manufacturers, and payors with referral coordination, prior auth support, patient education, financial assistance, and 24/7 pharmacist on-call coverage per the FAQ. FountainRx does not publish customer counts or order volumes on its public site as of June 2026 — ask directly if those metrics matter to your diligence.

Who needs this profile

Due diligence falls to the people signing the partnership.

A company profile matters most to roles responsible for vendor risk before a clinic refers patients. Three carry that weight.

  • Owners

    Founders accepting specialty partner risk.

    Owners want confirmation of licensure, accreditations, and independence before referring patients. FountainRx publishes URAC and ACHC credentials and 50-state licensure — strong public signals — but not referral volume or customer counts.

  • Operators

    Coordinators assessing reliability.

    Operations staff depend on coordinator responsiveness and referral turnaround. With volume metrics undisclosed publicly, they evaluate through pilot referrals, contract terms, and status-update quality rather than published scale figures.

  • Prescribers

    Providers confirming pharmacy legitimacy.

    Prescribers want assurance FountainRx is a licensed, accredited specialty pharmacy — not a similarly named unrelated entity. Accreditations, Tennessee headquarters, and fountainrx.com as the official domain are the public verification anchors.

Accreditations and licensure in plain terms

FountainRx's September 2024 announcement states four accreditations: URAC for specialty pharmacy and mail order, and ACHC for specialty pharmacy and compounding. URAC and ACHC are third-party quality programs common among specialty pharmacies — useful diligence signals when you compare referral partners. The same release states licensure in all 50 states for specialty pharmacy, recently adding Alabama and California.

FountainRx's public FAQ adds operational detail: Morristown hours Monday through Friday 8:30 a.m. to 5:30 p.m. EST, Nashville hours 8:00 a.m. to 6:00 p.m., and a pharmacist on call 24/7. Walk-in locations exist in Morristown and Nashville with delivery beyond those regions — consistent with a pharmacy, not a software-only ordering layer.

What to ask FountainRx directly

Because referral volume and customer counts are not public, request them in partnership discussions: ask which therapies your clinic would refer, expected prior auth turnaround, how provider status updates are delivered, and references from practices like yours. Confirm the contracting legal entity and BAA or HIPAA posture for patient data exchanged during referrals.

If your clinic also runs cash-pay GLP-1, hormone, and peptide batch ordering, FountainRx solves insured specialty coordination — not pass-through per-vial checkout. Fizy Health publishes its clinic commerce model openly: pass-through 503A pricing before payment, one cart, validation before checkout, and LegitScript-certified partners — the comparison point when your diligence spans both specialty referrals and cash-pay refill day.

After due diligence — which path fits your clinic?

FountainRx fits if

FountainRx

Specialty referral hub with prior auth and patient coordination.

  • You are satisfied with FountainRx's published accreditations, 50-state licensure, and referral coordination model for insured specialty patients.
  • Patient refill portals, education, and 24/7 pharmacist access matter more than clinic batch checkout for cash-pay protocols.
  • Your workflow is one patient referral at a time with care coordinators managing paperwork and status updates.
Consider Fizy Health if

Fizy Health

One cart for every patient today. Every pharmacy. One checkout.

  • You run cash-pay GLP-1, hormone, or peptide protocols and need pass-through per-vial 503A pricing visible before checkout.
  • You want SIG and licensure issues caught before payment — not after the pharmacy rejects the order.
  • You batch refills across multiple 503A partners and want one cart, one validation pass, one checkout.
If you choose Fizy Health

What your clinic gets from a transparent pass-through platform.

FountainRx and Fizy Health solve different problems. These outcomes apply to cash-pay batch ordering with visible pricing.

See all features
Keep evaluating FountainRx

More answers in the FountainRx evaluation guide.

See the full FountainRx guide
FAQ

Company questions clinics ask about FountainRx.

  • Company

    What is FountainRx as a company?

    FountainRx Specialty Pharmacy is a national, independently owned specialty and compounding pharmacy founded in Tennessee, operating since 2012, licensed in all 50 states as of September 2024, and accredited by URAC and ACHC per its public press release.

  • Leadership

    Who leads FountainRx?

    FountainRx's September 2024 press release names Joseph Huntsman as partner and chief executive officer and Ryan Hollingsworth, PharmD, as partner and chief operating officer.

  • Accreditations

    What accreditations does FountainRx hold?

    FountainRx states four accreditations: URAC for specialty pharmacy and mail order, and ACHC for specialty pharmacy and compounding, per its September 2024 announcement and public website.

  • Licensure

    Is FountainRx licensed nationally?

    FountainRx announced specialty pharmacy licensure in all 50 states in September 2024, including recent additions of Alabama and California, enabling nationwide patient service.

  • Customers

    How many clinics refer to FountainRx?

    FountainRx does not publish customer or referral counts on its public site as of June 2026. Ask directly for references from practices like yours rather than relying on an unverified number.

  • Alternative

    How does Fizy Health compare as a vendor profile?

    Fizy Health is an independent clinic ordering platform — not a specialty pharmacy — with pass-through per-vial 503A pricing before checkout, LegitScript-certified partners, and a BAA at onboarding. It complements FountainRx for cash-pay batch ordering rather than replacing specialty referral coordination.

Sources reviewed June 2026

  • FountainRx public website (fountainrx.com, referral process, FAQs), reviewed June 2026.
  • FountainRx September 2024 press release on leadership, 50-state licensure, and accreditations.
  • Fizy Health platform capabilities reflect the live product.
Evaluate with real numbers

Choose the right layer for each medication workflow.

Keep FountainRx for insured specialty referrals. See how Fizy Health shows landed cost before you quote on cash-pay batch lines. Free to start.

Fizy Health vs FountainRxStart Ordering Free